Skip to main content
logo
Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,175.00
-930.00 (-10.21%)
At close: Oct 11, 2024

Union Korea Pharm Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
25,45436,37851,28063,16961,29348,304
Revenue Growth
-40.07%-29.06%-18.82%3.06%26.89%-4.12%
Gross Profit
2,4867,75914,12420,78123,91715,150
Operating Income
-21,472-23,326-18,654-14,6821,271-10,615
Net Income
-24,302-30,820-20,916-18,156-932.02-11,109
Earnings Per Share
-4545.51-12789.27-8682.00-7543.35-378.93-4290.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
37,4326,5815,7617,1817,52421,120
Total Debt
5,21121,43323,99339,34937,12535,867
Net Cash (Debt)
32,222-14,853-18,232-32,169-29,601-14,747
Net Cash Growth
------
Net Cash Per Share
6026.76-6163.39-7567.77-13365.07-12034.97-5693.15

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1,564-1,134420.211,362-5,0631,915
Capital Expenditures
-78.57-95.74-949.44-2,263-3,366-7,168
Free Cash Flow
-1,643-1,230-529.23-901.15-8,429-5,254
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
9.77%21.33%27.54%32.90%39.02%31.36%
Operating Margin
-84.35%-64.12%-36.38%-23.24%2.07%-21.98%
Pretax Margin
-83.64%-76.44%-37.00%-22.80%1.54%-29.97%
Profit Margin
-95.47%-84.72%-40.79%-28.74%-1.52%-23.00%
FCF Margin
-6.45%-3.38%-1.03%-1.43%-13.75%-10.88%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.770.540.300.570.841.62